Literature DB >> 11450439

[Medicinal and chemical approaches to focused search of agents for treatment and therapy of Alzheimer disease].

S O Bachurin1.   

Abstract

The analysis and justification of medicinal chemistry approaches for focused search of novel agents for Alzheimer's disease (AD) and related disorders treatment and prevention have been reviewed. The systematization of modern biochemical and structural date related to the action of physiologically active compounds on the nervous system apparatus engaged in the AD-like disorders pathogenesis was performed. The major attention was paid to the cholinomimetic, anti-amyloid and antimetabolic approaches, basing on the results published in scientific literature in 3-4 last years and results of preclinical and clinical trials, presented in the internet database in the fall of 2000.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450439

Source DB:  PubMed          Journal:  Vopr Med Khim        ISSN: 0042-8809


  5 in total

1.  Novel conjugates of tacrine with 1,2,4,-thiadiazole as highly effective cholinesterase inhibitors, blockers of NMDA receptors, and antioxidants.

Authors:  G F Makhaeva; V V Grigoriev; A N Proshin; N V Kovaleva; E V Rudakova; N P Boltneva; I V Serkov; S O Bachurin
Journal:  Dokl Biochem Biophys       Date:  2018-01-03       Impact factor: 0.788

Review 2.  Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine).

Authors:  Aleksey Ustyugov; Elena Shevtsova; Sergey Bachurin
Journal:  Mol Neurobiol       Date:  2015-06-30       Impact factor: 5.590

3.  Synthesis and biological activity of N-substituted-tetrahydro-γ-carbolines containing peptide residues.

Authors:  Nadezhda V Sokolova; Valentine G Nenajdenko; Vladimir B Sokolov; Daria V Vinogradova; Elena F Shevtsova; Ludmila G Dubova; Sergey O Bachurin
Journal:  Beilstein J Org Chem       Date:  2014-01-15       Impact factor: 2.883

4.  The Dawn of Mitophagy: What Do We Know by Now?

Authors:  Dmitrii M Belousov; Elizaveta V Mikhaylenko; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

5.  Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.

Authors:  Galina F Makhaeva; Sofya V Lushchekina; Natalia P Boltneva; Vladimir B Sokolov; Vladimir V Grigoriev; Olga G Serebryakova; Ekaterina A Vikhareva; Alexey Yu Aksinenko; George E Barreto; Gjumrakch Aliev; Sergey O Bachurin
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.